Fusions of dendritic cells with breast carcinoma stimulate the expansion of regulatory T cells while concomitant exposure to IL-12, CpG oligodeoxynucleotides, and anti-CD3/CD28 promotes the expansion of activated tumor reactive cells.
about
Dendritic-Tumor Fusion Cell-Based Cancer VaccinesToll-like receptor mediated regulation of breast cancer: a case of mixed blessings.Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.Lenalidomide enhances anti-myeloma cellular immunityImmunologic monitoring of cellular responses by dendritic/tumor cell fusion vaccines.Can dendritic cells improve whole cancer cell vaccines based on immunogenically killed cancer cells?Trial watch: Dendritic cell-based interventions for cancer therapyHuman mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice.Breast cancer biology: the multifaceted roles of mesenchymal stem cells.Purified dendritic cell-tumor fusion hybrids supplemented with non-adherent dendritic cells fraction are superior activators of antitumor immunity.MUC1 immunotherapy.Cancer immunotherapy by fusions of dendritic cells and tumor cells.Regulation of tumor immunity by tumor/dendritic cell fusionsDendritic cell engineering for tumor immunotherapy: from biology to clinical translation.Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer.Membrane-tethered MUC1 mucin is phosphorylated by epidermal growth factor receptor in airway epithelial cells and associates with TLR5 to inhibit recruitment of MyD88.Antigen-specific polyclonal cytotoxic T lymphocytes induced by fusions of dendritic cells and tumor cells.Induction of antitumor immunity ex vivo using dendritic cells transduced with fowl pox vector expressing MUC1, CEA, and a triad of costimulatory molecules (rF-PANVAC).PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine.Therapeutic blockade of Foxp3 in experimental breast cancer models.
P2860
Q26744827-FE53200F-2C17-488C-90FF-D36CF955C354Q33658124-7EC3933B-C218-4238-BEB5-497490059B29Q33685495-B5BC1328-ABDD-4345-9138-6F37CC4B4ACAQ33903133-F008B110-469D-472D-A83D-C85538E8DF96Q34898366-EBF73FC4-713F-43CB-A83A-2341BFBB6732Q36255729-B7D9290E-4F57-43BE-A050-925D5A5878D3Q36388529-27DD506E-646F-4E13-B666-314F826EB558Q37050899-21CE7D92-1A7C-4C16-BF27-0A14C41C3D88Q37111274-FBC98D80-7F82-4525-A0B2-16E020370F6FQ37510538-8D8BEBF0-4810-4F4C-AFBC-4402343708A0Q37773241-86ECB40D-16F7-462D-A5DA-0F5237C57F0CQ37773276-E4D46589-043F-4826-9FA3-75985ED107FEQ37806963-E72D84B5-4F6E-424B-A4ED-28D0A8995370Q38031280-08044B18-48E6-4275-96F1-32EC0B2EDFF5Q39096364-CA22F3CF-09D8-4F71-B620-C749F3FDA6E9Q39411267-D18CE210-CA37-452C-B66E-F90AE64395A5Q39884422-7217FC31-BB8A-4DDA-A8C3-B28D854A47FEQ42089413-F36BA14E-EF01-466D-AA64-DDE25B2E341FQ42839507-EE94A610-EBC1-4133-A3C9-B3CACE6A7040Q48325267-36F7B63B-3BF7-4CB2-A111-2180ADB8C158
P2860
Fusions of dendritic cells with breast carcinoma stimulate the expansion of regulatory T cells while concomitant exposure to IL-12, CpG oligodeoxynucleotides, and anti-CD3/CD28 promotes the expansion of activated tumor reactive cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Fusions of dendritic cells wit ...... ctivated tumor reactive cells.
@en
type
label
Fusions of dendritic cells wit ...... ctivated tumor reactive cells.
@en
prefLabel
Fusions of dendritic cells wit ...... ctivated tumor reactive cells.
@en
P2093
P2860
P1476
Fusions of dendritic cells wit ...... ctivated tumor reactive cells.
@en
P2093
Adam Bissonnette
Baldev Vasir
Corrine Zarwan
David Avigan
Donald Kufe
Jacalyn Rosenblatt
Keith Crawford
P2860
P304
P356
10.4049/JIMMUNOL.181.1.808
P407
P577
2008-07-01T00:00:00Z